Bio Sidus Sa

This study tested if a new, potentially more affordable version of an existing Fabry disease drug works as well and is as safe. It involved 20 adult patients who were already stable on the standard treatment, Fabrazyme. For one year, researchers monitored if switching them to the…

This study aimed to see if a new version of an existing drug for Fabry Disease behaves the same way in the body. Researchers gave a single dose of either the original drug or a new version to 24 healthy male volunteers. They then took blood samples to measure drug levels and acti…